Bio-Techne Corp (TECH)

Official site

HEALTHCARE • BIOTECHNOLOGY • NASDAQ

$72.78

+0.12 (+0.17%)

Market Cap: $11.41B

Last updated: Nov 06, 2026 at 4:10 PM ET

Earnings

Performance (10Y)

Beat Rate

78%(31/40)

Avg Surprise

+5.47%

Upcoming Estimates

Period ending Dec 31, 2026

EPS Consensus$0.48

Range$0.46 - $0.51

6 analysts

EPS Revisions

30d

EPS Estimate DriftChange to current

90d ago$0.48-0.2%

60d ago$0.48-0.5%

30d ago$0.47+1.4%

7d ago$0.480.0%

Current$0.48

Revenue Consensus

$308M

Range$304M - $313M

7 analysts

Last 12 of 40 reported quarters and 1 upcoming estimate

Period	Reported	Est.	Range	Surprise	B/M	Analysts	Revisions	YoY
Dec 31, 2026Dec 26EST	-	$0.48	$0.46 - $0.51	-	-	6	1 0 30d	-
Sep 30, 2026Sep 26 Reported Nov 4, 2026Reported Nov 4	$0.36	$0.40	$0.36 - $0.44	-10.00%	Miss	7	1 0 30d	+0.0%
Jun 30, 2026Jun 26 Reported Aug 12, 2026Reported Aug 12	$0.49	$0.46	$0.45 - $0.47	+6.52%	Beat	11	0 1 30d	-7.5%
Mar 31, 2026Mar 26 Reported May 6, 2026Reported May 6	$0.53	$0.53	$0.51 - $0.56	+0.00%	Beat	12	1 8 30d	-5.4%
Dec 31, 2025Dec 25 Reported Feb 4, 2026Reported Feb 4	$0.46	$0.43	$0.41 - $0.46	+6.98%	Beat	12	0 1 30d	+9.5%
Sep 30, 2025Sep 25 Reported Nov 5, 2025Reported Nov 5	$0.36	$0.36	$0.33 - $0.40	+0.00%	Beat	13	0 2 30d	-14.3%
Jun 30, 2025Jun 25 Reported Aug 6, 2025Reported Aug 6	$0.53	$0.50	$0.47 - $0.52	+6.00%	Beat	15	0 1 30d	+8.2%
Mar 31, 2025Mar 25 Reported May 7, 2025Reported May 7	$0.56	$0.51	$0.49 - $0.52	+9.80%	Beat	11	1 2 30d	+16.7%
Dec 31, 2024Dec 24 Reported Feb 5, 2025Reported Feb 5	$0.42	$0.39	$0.36 - $0.40	+7.69%	Beat	11	4 4 30d	+5.0%
Sep 30, 2024Sep 24 Reported Oct 30, 2024Reported Oct 30	$0.42	$0.38	$0.35 - $0.42	+10.53%	Beat	13	No revisions (30d)	+2.4%
Jun 30, 2024Jun 24 Reported Aug 7, 2024Reported Aug 7	$0.49	$0.49	$0.46 - $0.52	+0.00%	Beat	13	No revisions (30d)	-10.9%
Mar 31, 2024Mar 24 Reported May 1, 2024Reported May 1	$0.48	$0.46	$0.42 - $0.50	+4.35%	Beat	12	1 1 30d	-9.4%
Dec 31, 2023Dec 23 Reported Feb 1, 2024Reported Feb 1	$0.40	$0.41	$0.38 - $0.45	-2.44%	Miss	12	No revisions (30d)	-14.9%

Dividends

Next ex-dividend: Nov 13, 2026

Dividend Metrics

Forward Yield0.44%

Forward Annual Dividend$0.32

Payout Ratio14.86%

FrequencyQuarterly

Pay MonthsFeb, May, Sep, Nov

Growth

3Y CAGR+0.00%

5Y CAGR+0.00%

TECH dividend history and ex-dividend dates Run TECH in the free DRIP calculator

Key Metrics

Valuation
P/E Ratio	39.55	EV/EBITDA	33.36x
Price/FCF	37.03x	FCF Yield	2.70%
Profitability
Profit Margin	15.00%	Operating Margin	27.90%
ROE	9.03%	ROIC	7.70%
Financial Health
Debt/Equity	0.09x	Interest Coverage	25.55x
Current Ratio	2.28x	Quick Ratio	1.74x
Trading Statistics
Beta	1.27	Avg Volume	2.91M
52-Week High	$72.83	52-Week Low	$43.02

Technical Indicators Dashboard

Moving Averages

SMA 10$72.69

SMA 20$72.62

SMA 50$72.48

SMA 200$63.15

EMA 10$72.68

EMA 20$72.62

EMA 50$72.05

EMA 200$65.58

MACD

Line: 0.08Signal: 0.09Hist: -0.00

ADX

ADX: 46.6+DI: 19.8-DI: 9.1

Aroon & PSAR

Aroon Up92.0

Aroon Down4.0

PSAR$72.59

Bollinger Bands

Upper Band$72.79

Lower Band$72.45

%B Position47%(Middle)

Band Width0.98

RSI (14-Day)

Neutral

61.2

Momentum Oscillators

Stoch %K70.7

Stoch %D69.5

Williams %R-14.3

ROC (10d)0.3%

Momentum0.23

CCI (20d)108.1

MFI (14d)64.8

Volatility Measures

ATR (14d)$0.14(0.2%)

StdDev (20d)0.09

Hist Vol1.6%(Low)

Volume Flow

VWAP$72.74

OBV109.8M

AD Line-135.1M

CMF (20d)-0.123

Volume Metrics

Avg Vol (20d)2.8M

Vol Ratio0.7x

VWMA (20d)$72.63

Pivot Points

R3$72.89

R2$72.85

R1$72.75

Pivot Point$72.71

S1$72.61

S2$72.57

S3$72.47

Advanced Oscillators

TSI16.26

Ultimate Osc45.3

KST3.11

Financial Data

Quarter	Sep 2026	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023
Total Revenue	$299.71M	$321.19M	$311.42M	$295.88M	$286.56M	$316.96M	$316.18M	$297.03M	$289.46M	$306.10M	$303.43M	$272.60M
Cost of Revenue	$103.09M	$109.80M	$103.13M	$104.60M	$98.44M	$118.15M	$101.63M	$103.14M	$106.44M	$102.75M	$98.83M	$96.01M
Gross Profit	$196.62M	$211.39M	$208.29M	$191.28M	$188.11M	$198.81M	$214.56M	$193.89M	$183.02M	$203.35M	$204.60M	$176.59M

Operating Expenses	$160.02M	$137.12M	$132.79M	$136.82M	$140.45M	$222.67M	$175.85M	$146.47M	$143.03M	$157.53M	$137.60M	$138.58M
R&D	$26.34M	$23.95M	$23.45M	$23.13M	$24.24M	$26.03M	$24.58M	$25.02M	$23.87M	$23.99M	$25.76M	$22.92M
SG&A	$133.68M	$113.17M	$109.34M	$113.69M	$116.21M	$196.64M	$151.27M	$121.45M	$119.16M	$133.54M	$111.84M	$115.67M
Operating Income	$36.60M	$74.28M	$75.50M	$54.46M	$47.66M	$-23,859,000	$38.71M	$47.42M	$39.99M	$45.82M	$67.00M	$38.00M

Interest Income	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Interest Expense	$1.91M	$3.60M	$4.27M	$3.68M	$0	$0	$434,000	$4.54M	$0	$4.16M	$5.91M	$4.62M
Income Before Tax	$34.69M	$70.68M	$71.22M	$50.78M	$47.99M	$-22,858,000	$38.27M	$42.88M	$40.17M	$41.66M	$61.08M	$33.39M
Income Tax Expense	$6.40M	$16.06M	$20.18M	$12.78M	$9.81M	$-5,180,000	$15.69M	$7.99M	$6.57M	$1.07M	$12.03M	$5.92M

Net Income	$28.29M	$54.62M	$51.05M	$38.01M	$38.19M	$-17,678,000	$22.59M	$34.89M	$33.60M	$40.59M	$49.06M	$27.46M

EBITDA	$60.33M	$98.42M	$99.66M	$79.17M	$72.00M	$3.25M	$66.28M	$74.50M	$68.12M	$73.88M	$94.31M	$61.19M
EBIT	$36.60M	$74.28M	$75.50M	$54.46M	$47.66M	$-23,859,000	$38.71M	$47.42M	$39.99M	$45.82M	$67.00M	$33.39M

* Some calculated fields are derived from available data when not provided by source

Related GNG Research

No research available

Be the first to write about TECH

News

Bio-Techne 3Q 2026: Revenue $299.71M, EPS $0.18 — 10-Q Summary

Bio-Techne reported its first-quarter fiscal 2027 net sales increased 5% year over year to $299.71 million, while net earnings declined by 25.9% to $28.29 million...

TradingView•Nov 6, 2026 4:41 PM ET11/6/26•Somewhat-Bearish

Sales rise 5% at Bio-Techne (TECH), but quarterly earnings move the other way.

Bio-Techne (TECH) reported a 5% increase in net sales to $299.712 million for Q1 fiscal 2027, up from $286.555 million in the prior year. Despite rising sales...

Stock Titan•Nov 6, 2026 4:32 PM ET11/6/26•Neutral

FMR LLC and Abigail P. Johnson Report 0.7% Stake in Bio-Techne Corp via 13G Amendment

FMR LLC and Abigail P. Johnson have filed an Amendment No. 2 to their Schedule 13G, disclosing a beneficial ownership of 1,088,114.27 shares, representing 0.7% of Bio-Techne Corp's outstanding common stock. This filing...

Kalkine Media•Nov 5, 2026 1:38 PM ET11/5/26•Neutral

Bio-Techne (TECH) Stock Trades Above Fair Value On Cash Flow Estimates

Bio-Techne's stock (TECH) is currently trading above its estimated intrinsic value based on a Discounted Cash Flow (DCF) model...

Simply Wall St•Nov 4, 2026 5:37 AM ET11/4/26•Somewhat-Bearish

Bio-Techne earnings missed by $0.03, revenue fell short of estimates

Bio-Techne (NASDAQ: TECH) reported third-quarter earnings per share (EPS) of $0.42, missing the analyst estimate of $0.45 by $0.03. Revenue for the quarter was $292.7 million...

Investing.com•Nov 3, 2026 11:24 PM ET11/3/26•Bearish

TECH Valuation and Fair Value

P/E: 39.6x
Forward P/E: 35.7x
EV/EBITDA: 33.4x
P/FCF: 37.0x
PEG: 2.2x
P/B: 5.3x

See GNG's fair value

TECH Profitability: Margins, ROIC and FCF

Gross margin: 65.8%
Operating margin: 27.9%
Net margin: 15.0%
ROIC: 7.7%
ROE: 9.0%
FCF margin: 25.1%
FCF yield: 2.7%

TECH Competitors

Company	Ticker
Universal Health Services Inc	UHS
Align Technology Inc	ALGN
Elanco Animal Health	ELAN
Molina Healthcare Inc	MOH
Fresenius Medical Care Corporation	FMS
Kymera Therapeutics Inc	KYMR
DaVita HealthCare Partners Inc	DVA
Globus Medical	GMED

Sector: Healthcare

TECH Analyst Ratings

Consensus: Hold
Analysts: 13
Strong Buy: 0
Buy: 1
Hold: 12
Sell: 0
Strong Sell: 0

TECH Bull Case vs Bear Case

Bull case

TECH converts 25.1% of revenue into free cash flow.

TECH Earnings: Beat Rate and Next Report

Beat rate: 5 of 8 quarters (62.5%)
Average surprise: 3.4%
EPS estimate (fiscal period ending Dec 31, 2026): $0.48
Estimate revisions (30 days, fiscal period ending Dec 31, 2026): 1 up, 0 down

TECH Dividend

Forward yield: 0.4%
Payout ratio: 14.9%
3Y DPS growth: 0.0%
5Y DPS growth: 0.0%
Pay months: Feb, May, Sep, Nov

TECH dividend history

TECH Earnings Date

TECH reports Feb 2, 2027. The date is confirmed.

TECH Earnings Call

The latest TECH earnings call transcript on file is labeled 2026Q3.

Read the 2026Q3 transcript

TECH ETF Holders

GNG tracks 36 ETFs that hold TECH. The largest weights:

Invesco S&P 500 Equal Weight Health Care ETF (RSPH), 1.65% of the fund
NYLIM Merger Arbitrage ETF (MNA), 1.47% of the fund
SMOT, 0.89% of the fund
iShares Biotechnology ETF (IBB), 0.79% of the fund
Vanguard Morningstar Small-Cap Growth ETF (VBK), 0.32% of the fund

Open the ETF Stock Exposure tool for TECH

See insider activity

Frequently Asked Questions About TECH

When is TECH's next ex-dividend date?

TECH's next ex-dividend date is Nov 13, 2026, for a declared dividend of $0.08 per share (record date Nov 13, 2026, payable Nov 23, 2026).

When does TECH report earnings?

Bio-Techne Corp (TECH) is confirmed to report earnings on Feb 2, 2027.

What is TECH's current dividend yield?

Bio-Techne Corp (TECH) has a forward dividend yield of 0.44%.

Does TECH pay dividends?

Yes, Bio-Techne Corp pays dividends with a forward dividend yield of 0.44%.

What is TECH's P/E ratio?

Bio-Techne Corp has a price-to-earnings (P/E) ratio of 39.55.

Get full access to GNG Research

Create a free account to access portfolio tracking, advanced tools, and more.

Create Free Account Log In